Primary intracranial plasma cell granuloma responsive to rituximab

Neurology. 2014 Sep 16;83(12):1119-20. doi: 10.1212/WNL.0000000000000799. Epub 2014 Aug 8.

Authors

Christian Schneider¹, Tobias D Henning¹, Gereon R Fink¹, Michael Schroeter¹, Helmar C Lehmann²

Affiliations

¹ From the University Hospital of Cologne (C.S., T.D.H., G.R.F., M.S., H.C.L.); and the Institute of Neuroscience and Medicine (INM-3) (G.R.F.), Research Center Jülich, Germany.
² From the University Hospital of Cologne (C.S., T.D.H., G.R.F., M.S., H.C.L.); and the Institute of Neuroscience and Medicine (INM-3) (G.R.F.), Research Center Jülich, Germany. helmar.lehmann@uk-koeln.de.

PMID: 25107881
DOI: 10.1212/WNL.0000000000000799

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antibodies, Monoclonal, Murine-Derived / therapeutic use*
Brain / pathology
Brain Diseases / diagnosis
Brain Diseases / drug therapy*
Female
Granuloma, Plasma Cell / diagnosis
Granuloma, Plasma Cell / drug therapy*
Humans
Immunologic Factors / therapeutic use*
Magnetic Resonance Imaging
Rituximab
Treatment Outcome

Substances

Antibodies, Monoclonal, Murine-Derived
Immunologic Factors
Rituximab